Ichikawa J - Search Results

1

Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.

Ichikawa J, Li Z, Dai J, Meltzer HY. Ichikawa J, et al. Brain Res. 2002 Nov 29;956(2):349-57. doi: 10.1016/s0006-8993(02)03570-9. Brain Res. 2002. PMID: 12445705

2

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.

Li Z, Ichikawa J, Dai J, Meltzer HY. Li Z, et al. Among authors: ichikawa j. Eur J Pharmacol. 2004 Jun 16;493(1-3):75-83. doi: 10.1016/j.ejphar.2004.04.028. Eur J Pharmacol. 2004. PMID: 15189766

3

Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.

Huang M, Li Z, Ichikawa J, Dai J, Meltzer HY. Huang M, et al. Among authors: ichikawa j. Brain Res. 2006 Jul 12;1099(1):44-55. doi: 10.1016/j.brainres.2006.04.081. Epub 2006 Jul 7. Brain Res. 2006. PMID: 16824491

4

ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY. Li Z, et al. Among authors: ichikawa j. Psychopharmacology (Berl). 2005 Dec;183(2):144-53. doi: 10.1007/s00213-005-0170-9. Epub 2005 Nov 9. Psychopharmacology (Berl). 2005. PMID: 16220333

5

Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release.

Ichikawa J, Chung YC, Dai J, Meltzer HY. Ichikawa J, et al. Brain Res. 2005 Aug 2;1052(1):56-62. doi: 10.1016/j.brainres.2005.06.009. Brain Res. 2005. PMID: 16061211

6

Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.

Ichikawa J, Dai J, Meltzer HY. Ichikawa J, et al. Brain Res. 2005 Jul 12;1049(2):182-90. doi: 10.1016/j.brainres.2005.05.005. Brain Res. 2005. PMID: 15936730

7

N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.

Li Z, Huang M, Ichikawa J, Dai J, Meltzer HY. Li Z, et al. Among authors: ichikawa j. Neuropsychopharmacology. 2005 Nov;30(11):1986-95. doi: 10.1038/sj.npp.1300768. Neuropsychopharmacology. 2005. PMID: 15900318

8

Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism.

Chung YC, Li Z, Dai J, Meltzer HY, Ichikawa J. Chung YC, et al. Among authors: ichikawa j. Brain Res. 2004 Oct 8;1023(1):54-63. doi: 10.1016/j.brainres.2004.07.009. Brain Res. 2004. PMID: 15364019

9

Serotonin receptors: their key role in drugs to treat schizophrenia.

Meltzer HY, Li Z, Kaneda Y, Ichikawa J. Meltzer HY, et al. Among authors: ichikawa j. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1159-72. doi: 10.1016/j.pnpbp.2003.09.010. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 14642974 Review.

10

5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

Kuroki T, Meltzer HY, Ichikawa J. Kuroki T, et al. Among authors: ichikawa j. Brain Res. 2003 May 16;972(1-2):216-21. doi: 10.1016/s0006-8993(03)02516-2. Brain Res. 2003. PMID: 12711095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results